Elevance Health Inc
ELV: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|th | LOCK|jTymB | LOCK|^<j$YS |
Elevance Earnings: 2026 Outlook Rises on Better-Than-Expected Margins
On Oct. 21, Elevance reported third-quarter results that included 1% operating revenue growth and 16% adjusted EPS growth to $6.99, or well above FactSet consensus of $4.71. Management also raised its 2026 adjusted EPS guidance to at least $29, up from $27 previously.
